Advertisement

Globalizzazione e salute: nuove prospettive e nuovi rischi nell’era della genomica

  • Anna Maria Rossi
Chapter
  • 157 Downloads

Estratto

Il binomio globalizzazione/salute salta usualmente alla ribalta di fronte alle emergenze sanitarie come la SARS1, o più recentemente l’influenza aviaria, che godono fin troppo spesso dell’onore delle cronache. Considerata la velocità con cui si possono diffondere nuovi germi patogeni, giustamente è cresciuta la preoccupazione per il rischio di pandemie. Tuttavia, possiamo sentirci rassicurati, almeno in parte, dal fatto che la globalizzazione si porta dietro anche un’elevata capacità di rispondere alle emergenze su scala planetaria, com’è successo per il controllo della diffusione della SARS e si spera che succeda nel caso dell’influenza aviaria.

Bibliografia

  1. 1.
    Huynen MM, Martens P, Hilderink HB (2005) The health impacts of globalization: a conceptual framework. Global Health 3:1–14. http://www.globalizationandhealth.com/content/1/1/14Google Scholar
  2. 2.
    Art. 25 della Dichiarazione universale dei diritti dell’uomo, 1948Google Scholar
  3. 3.
    Morel C, Broun D, Dangi A e coll (2005) Health Innovation in Developing Countries to Address Diseases of the Poor. Innovation Strategy Today 1:1–15. www.biodevelopments.orgGoogle Scholar
  4. 4.
    United Nations (2000) United Nations Millennium Development Goals. United Nations, New York. http://www.un.org/millenniumgoals/Google Scholar
  5. 5.
    Collins T (2003) Globalization, global health and access to care. Int J Health Plann Manege 18:97–104CrossRefGoogle Scholar
  6. 6.
    World Health Organization (2002) Genomics and world health: Report of the Advisory Committee on Health Research. World Health Organization, Geneva. http://www3.who.int/whosis/genomics/pdf/genomics_report.pdfGoogle Scholar
  7. 7.
    United Nations Millennium Project Task Force on Science, Technology and Innovation (2004) Interim Report of Task Force 10 on Science, Technology, and Innovation. Commissioned by the UN Secretary General. United Nations, New York. http://www.unmillenniumproject.org/documents/tf10interim.pdfGoogle Scholar
  8. 8.
    Dulbecco R (1986) A turning point in cancer research: sequencing the human genome. Science 231:1055–1056CrossRefGoogle Scholar
  9. 9.
    http://www.wellcome.ac.uk/Google Scholar
  10. 10.
    http://www.telethon.it/Google Scholar
  11. 11.
    http://www.celera.com/Google Scholar
  12. 12.
    www.genegateway.com/ fornisce una guida per il pubblico interessato ma non specialistico, mentre http://www.ornl.gov/sci/techresources/Human_Genome/home.shtml è un sito più tecnico, ma certamente più completoGoogle Scholar
  13. 13.
    Daar AS, Thorsteinsdóttir H, Martin DK e coll (2002) Top ten biotechnologies for improving health in developing countries. Nat Genet 32:229–232CrossRefGoogle Scholar
  14. 14.
    Beck IA, Drennan KD, Melvin AJ e coll (2001) Simple, sensitive, and specific detection of human immunodeficiency virus type 1 subtype B DNA in dried blood samples for diagnosis in infants in the field. J Clin Microbiol 39:29–33CrossRefGoogle Scholar
  15. 15.
    Malaria Vaccine Initiative http://www.malariavaccine.orgGoogle Scholar
  16. 16.
    Wiesner J, Borrmann S, Jomaa H (2003) Fosmidomycin for the treatment of malaria. Parasitol Res 90[Suppl 2]:S71–S76CrossRefGoogle Scholar
  17. 17.
    Global Forum for Health Research (2000) The 10/90 Report on Health Research. Global Forum for Health Research, GenevaGoogle Scholar
  18. 18.
    Jodar L, LaForce FM, Ceccarini C e coll (2003) Meningococcal conjugate vaccine for Africa: a model for development of new vaccines for the poorest countries. Lancet 361:1902–1904CrossRefGoogle Scholar
  19. 19.
    Acharya T, Daar AS, Thorsteinsdóttir H e coll (2004) Strengthening the Role of Genomics in Global Health. PLoS Medicine 1:195–197. www.plosmedicine.orgCrossRefGoogle Scholar
  20. 20.
    Thorsteinsdottir H, Quach U, Martin DK e coll (2004) Introduction: promoting global health through biotechnology. Nat Biotechnol 22[Suppl]:DC3–DC7CrossRefGoogle Scholar
  21. 21.
    Mashelkar RA (2005) Nation Building through Science & Technology: A Developing World Perspective-10th Zuckerman Lecture, Royal Society, London. Innovation Strategy Today 1:16–32. www.biodevelopments.orgGoogle Scholar
  22. 22.
    Kumar NK, Quach U, Thorsteinsdottir H e coll (2004) Indian biotechnology-rapidly evolving and industry led. Nat Biotechnol 22[Suppl]:DC31–DC36CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2007

Authors and Affiliations

  • Anna Maria Rossi
    • 1
  1. 1.Dipartimento di BiologiaUniversità di PisaPisa

Personalised recommendations